Skip to main content
Top
Published in: Clinical Rheumatology 6/2016

01-06-2016 | Review Article

Physical activity in axial spondyloarthritis—tails from bench to bedside

Author: Lianne S. Gensler

Published in: Clinical Rheumatology | Issue 6/2016

Login to get access

Abstract

Physical therapy and exercise (recreational activity) are the cornerstones of non-pharmacologic therapy in axial spondyloarthritis (AxSpA) [1, 2]. These are components of physical activity, though physical activity is made up of activities beyond these and also include occupational activity. Not all activities in AxSpA appear to derive the same benefit for patients. In fact, it might be that while some activities are extremely beneficial for disease activity, function, and other outcomes, other activities may be harmful for the disease. The following review will examine animal model-based evidence and epidemiologic studies on physical activity in AxSpA.
Literature
1.
go back to reference Ward MM, Deodhar A, Akl EA, et al. (2015) American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis. Arthritis & Rheumatology 1–17. doi: 10.1002/ART.39298 Ward MM, Deodhar A, Akl EA, et al. (2015) American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis. Arthritis & Rheumatology 1–17. doi: 10.​1002/​ART.​39298
2.
go back to reference van den Berg R, Baraliakos X, Braun J, van der Heijde D (2012) First update of the current evidence for the management of ankylosing spondylitis with non-pharmacological treatment and non-biologic drugs: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis. Rheumatology 51:1388–1396. doi:10.1093/rheumatology/kes066 CrossRefPubMed van den Berg R, Baraliakos X, Braun J, van der Heijde D (2012) First update of the current evidence for the management of ankylosing spondylitis with non-pharmacological treatment and non-biologic drugs: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis. Rheumatology 51:1388–1396. doi:10.​1093/​rheumatology/​kes066 CrossRefPubMed
3.
go back to reference Starkie R, Ostrowski SR, Jauffred S, et al. Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans. FASEB J 884–886 Starkie R, Ostrowski SR, Jauffred S, et al. Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans. FASEB J 884–886
5.
go back to reference van der Heijde D, Landewe R, Einstein S et al (2008) Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept. Arthritis Rheum 58:1324–1331. doi:10.1002/art.23471 CrossRefPubMed van der Heijde D, Landewe R, Einstein S et al (2008) Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept. Arthritis Rheum 58:1324–1331. doi:10.​1002/​art.​23471 CrossRefPubMed
6.
go back to reference Heijde DVD (2009) Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2years. Arthritis Research & Therapy 1–8. doi: 10.1186/ar2794) Heijde DVD (2009) Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2years. Arthritis Research & Therapy 1–8. doi: 10.​1186/​ar2794)
7.
go back to reference Heijde DVD, Landewé R, Baraliakos X et al (2008) Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis. Arthritis Rheum 58:3063–3070. doi:10.1002/art.23901 CrossRefPubMed Heijde DVD, Landewé R, Baraliakos X et al (2008) Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis. Arthritis Rheum 58:3063–3070. doi:10.​1002/​art.​23901 CrossRefPubMed
8.
go back to reference Baraliakos X, Heldmann F, Callhoff J et al (2014) Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and conventional radiography. Ann Rheum Dis 73:1819–1825. doi:10.1136/annrheumdis-2013-203425 CrossRefPubMed Baraliakos X, Heldmann F, Callhoff J et al (2014) Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and conventional radiography. Ann Rheum Dis 73:1819–1825. doi:10.​1136/​annrheumdis-2013-203425 CrossRefPubMed
9.
go back to reference Chiowchanwisawakit P, Lambert RGW, Conner-Spady B, Maksymowych WP (2011) Focal fat lesions at vertebral corners on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis. Arthritis Rheum 63:2215–2225. doi:10.1002/art.30393 CrossRefPubMed Chiowchanwisawakit P, Lambert RGW, Conner-Spady B, Maksymowych WP (2011) Focal fat lesions at vertebral corners on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis. Arthritis Rheum 63:2215–2225. doi:10.​1002/​art.​30393 CrossRefPubMed
10.
go back to reference van der Heijde D, Machado P, Braun J et al (2012) MRI inflammation at the vertebral unit only marginally predicts new syndesmophyte formation: a multilevel analysis in patients with ankylosing spondylitis. Ann Rheum Dis 71:369–373. doi:10.1136/annrheumdis-2011-200208 CrossRefPubMed van der Heijde D, Machado P, Braun J et al (2012) MRI inflammation at the vertebral unit only marginally predicts new syndesmophyte formation: a multilevel analysis in patients with ankylosing spondylitis. Ann Rheum Dis 71:369–373. doi:10.​1136/​annrheumdis-2011-200208 CrossRefPubMed
11.
go back to reference Buchbender, C., Ostendorf, B., Ruhlmann, V., Heusch, P., Miese, F., Beiderwellen, K., et al. (2015) Hybrid 18F-labeled Fluoride Positron Emission Tomography/Magnetic Resonance (MR) Imaging of the Sacroiliac Joints and the Spine in Patients with Axial Spondyloarthritis: A Pilot Study Exploring the Link of MR Bone Pathologies and Increased Osteoblastic Activity. J Rheumatol 42(9):1631–1637. doi:10.3899/jrheum.150250 Buchbender, C., Ostendorf, B., Ruhlmann, V., Heusch, P., Miese, F., Beiderwellen, K., et al. (2015) Hybrid 18F-labeled Fluoride Positron Emission Tomography/Magnetic Resonance (MR) Imaging of the Sacroiliac Joints and the Spine in Patients with Axial Spondyloarthritis: A Pilot Study Exploring the Link of MR Bone Pathologies and Increased Osteoblastic Activity. J Rheumatol 42(9):1631–1637. doi:10.​3899/​jrheum.​150250
12.
go back to reference Pedersen SJ, Chiowchanwisawakit P, Lambert RG et al (2011) Resolution of inflammation following treatment of ankylosing spondylitis is associated with new bone formation. J Rheumatol 38:1349–1354CrossRefPubMed Pedersen SJ, Chiowchanwisawakit P, Lambert RG et al (2011) Resolution of inflammation following treatment of ankylosing spondylitis is associated with new bone formation. J Rheumatol 38:1349–1354CrossRefPubMed
13.
go back to reference Maksymowych WP, Elewaut D, Schett G (2012) Motion for debate: the development of ankylosis in ankylosing spondylitis is largely dependent on inflammation. Arthritis Rheum 64:1713–1719. doi:10.1002/art.34442 CrossRefPubMed Maksymowych WP, Elewaut D, Schett G (2012) Motion for debate: the development of ankylosis in ankylosing spondylitis is largely dependent on inflammation. Arthritis Rheum 64:1713–1719. doi:10.​1002/​art.​34442 CrossRefPubMed
14.
go back to reference McGonagle D, Thomas RC, Schett G (2013) Spondyloarthritis: may the force be with you? Annals of the Rheumatic Diseases 321–323 McGonagle D, Thomas RC, Schett G (2013) Spondyloarthritis: may the force be with you? Annals of the Rheumatic Diseases 321–323
18.
go back to reference Braem K, Carter S, Lories RJ (2012) Spontaneous arthritis and ankylosis in male DBA/1 mice: further evidence for a role of behavioral factors in “stress-induced arthritis.”. Bio Proced Online 14:1–1. doi:10.1186/1480-9222-14-10 CrossRef Braem K, Carter S, Lories RJ (2012) Spontaneous arthritis and ankylosis in male DBA/1 mice: further evidence for a role of behavioral factors in “stress-induced arthritis.”. Bio Proced Online 14:1–1. doi:10.​1186/​1480-9222-14-10 CrossRef
22.
go back to reference Ward MM, Deodhar A, Akl EA, et al. (2015) American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis. Arthritis Care Res 1–16. doi: 10.1002/acr.22708 Ward MM, Deodhar A, Akl EA, et al. (2015) American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis. Arthritis Care Res 1–16. doi: 10.​1002/​acr.​22708
23.
go back to reference Patterson SL, Reveille JD, Lee M, Ward MM, Rahbar MH, Brown MA, et al. (2014) Better Outcomes in Ankylosing Spondylitis: The Synergistic Association Between Exercise and Tumor Necrosis Factor Inhibitors. Arthritis & Rheumatology. 66:250–251 Patterson SL, Reveille JD, Lee M, Ward MM, Rahbar MH, Brown MA, et al. (2014) Better Outcomes in Ankylosing Spondylitis: The Synergistic Association Between Exercise and Tumor Necrosis Factor Inhibitors. Arthritis & Rheumatology. 66:250–251
24.
go back to reference Bernard B (Editor) (1997) Musculoskeletal disorders and workplace factors: a critical review of epidemiologic evidence for work- related musculoskeletal disorders of the neck, upper extremity, and low back. National Institute of Occupational Safety and Health (NIOSH) publication number 97-141. Cincinnati (OH): US Department of Health and Human Services Bernard B (Editor) (1997) Musculoskeletal disorders and workplace factors: a critical review of epidemiologic evidence for work- related musculoskeletal disorders of the neck, upper extremity, and low back. National Institute of Occupational Safety and Health (NIOSH) publication number 97-141. Cincinnati (OH): US Department of Health and Human Services
25.
go back to reference Anderson JH, Haahr JP, Frost P (2007) Risk factors for more severe regional musculoskeletal symptoms: a two-year prospective study of a general working population. Arthritis Rheum 1355–1364 Anderson JH, Haahr JP, Frost P (2007) Risk factors for more severe regional musculoskeletal symptoms: a two-year prospective study of a general working population. Arthritis Rheum 1355–1364
26.
go back to reference DSouza JC, Franzblau A, Werner RA (2005) Review of epidemiologic studies on occupational factors and lower extremity musculoskeletal and vascular disorders and symptoms. J Occup Rehabil 129–165 DSouza JC, Franzblau A, Werner RA (2005) Review of epidemiologic studies on occupational factors and lower extremity musculoskeletal and vascular disorders and symptoms. J Occup Rehabil 129–165
27.
go back to reference Ward MM, Weisman MH, Davis JCJ, Reveille JD (2005) Risk Factors for Functional Limitations in Patients with Long-Standing Ankylosing Spondylitis. Arth Rheum 710–717. doi: 10.1002/art.21444 Ward MM, Weisman MH, Davis JCJ, Reveille JD (2005) Risk Factors for Functional Limitations in Patients with Long-Standing Ankylosing Spondylitis. Arth Rheum 710–717. doi: 10.​1002/​art.​21444
29.
go back to reference Ramiro S, Landewé R, van Tubergen A, et al. (2015) Lifestyle factors may modify the effect of disease activity on radiographic progression in patients with ankylosing spondylitis: a longitudinal analysis. RMD Open 1–8. doi: 10.1136/rmdopen-2015-000153 Ramiro S, Landewé R, van Tubergen A, et al. (2015) Lifestyle factors may modify the effect of disease activity on radiographic progression in patients with ankylosing spondylitis: a longitudinal analysis. RMD Open 1–8. doi: 10.​1136/​rmdopen-2015-000153
Metadata
Title
Physical activity in axial spondyloarthritis—tails from bench to bedside
Author
Lianne S. Gensler
Publication date
01-06-2016
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 6/2016
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-016-3264-3

Other articles of this Issue 6/2016

Clinical Rheumatology 6/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.